骨髓细胞ACE塑造了PCSK-9诱导的动脉样硬化中的细胞代谢和功能
DuoYao Cao1, Suguru Saito1, LiMin Xu2
1Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Frontiers in immunology
|November 6, 2023
概括
在髓状细胞中过度表达血管酶转化酶 (ACE) 会增强单细胞和巨细胞中的脂质代谢,防止动脉样硬化进展. 单细胞中的这种代谢转变是防止斑块积累的关键.
科学领域:
- 心血管生物学 心血管生物学
- 免疫代谢过程中的免疫代谢.
- 动脉样硬化病原体的产生
背景情况:
- 动脉样硬化病原包括受损的巨细胞脂质处理和慢性炎症.
- 巨细胞特异性血管酶转化酶 (ACE) 的过度表达可以保护小鼠免受动脉样硬化.
- ACE在外周血液单细胞,巨细胞前体中的作用尚不清楚.
研究的目的:
- 为了研究ACE在动脉样硬化中的外周血液单细胞中的作用.
- 为了确定单细胞中ACE过度表达是否会影响它们分化为巨细胞.
- 评估ACE介导的单细胞代谢变化对动脉样硬化进展的影响.
主要方法:
- 使用ACE10/10转基因小鼠,增加了巨细胞特异性ACE.
- 在动脉样硬化的条件下分析了外周血液单细胞群 (Ly-6Clo).
- 评估了分离单细胞中的脂质代谢,线粒体活性和ATP水平.
- 测量了小鼠的氧气消耗 (VO2),呼吸交换率 (RER) 和身体活动.
主要成果:
- 骨髓系细胞中的ACE过度表达改变了循环单细胞的新陈代谢.
- ACE10/10小鼠表现出增加的Ly-6Clo单细胞与增强的脂质代谢和线粒体活动.
- 在ACE10/10小鼠中观察到系统能量消耗增加 (VO2,RER,体力活动).
- 单细胞的功能性修改转移到分化的巨细胞,防止斑块的进展.
结论:
- 通过ACE介导的代谢表型存在于动脉样硬化的循环单细胞中.
- 骨髓细胞中的ACE过度表达增强了单细胞和巨细胞的脂质代谢.
- 单细胞和巨细胞的这种代谢重编程可以防止动脉样硬化病变的进展.
相关概念视频
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Inflammation
53.7K
Overview
53.7K
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9


